Medenica, R <br/><br/>
Clinical results of leukocyte interferon-induced tumor regression in resistant human metastatic cancer resistant to chemotherapy and/or radiotherapy-pulse therapy schedule.  [electronic resource] 

 -  Cancer drug delivery  1985 
 - 53-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-9482 
<br/><br/><label>Standard No.: </label>10.1089/cdd.1985.2.53  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--therapy<br/>Adult<br/>Astrocytoma--therapy<br/>Breast Neoplasms--therapy<br/>Carcinoma, Renal Cell--therapy<br/>Carcinoma, Squamous Cell--therapy<br/>Combined Modality Therapy<br/>Drug Evaluation<br/>Female<br/>Head and Neck Neoplasms--therapy<br/>Humans<br/>Interferon Type I--adverse effects<br/>Kidney Neoplasms--therapy<br/>Male<br/>Melanoma--therapy<br/>Middle Aged<br/>Multiple Myeloma--therapy<br/>Neoplasm Metastasis<br/>Neoplasms--drug therapy<br/>Ovarian Neoplasms--therapy<br/>Prostatic Neoplasms--therapy<br/>Stomach Neoplasms--drug therapy